news
A study has shown that in mice, the GKT137831 drug…
3 March 2020 | By Victoria Rees (Drug Target Review)
A study has shown that in mice, the GKT137831 drug makes tumours more sensitive to immunotherapy, so could be used to improve cancer treatments.